NasdaqCM - Delayed Quote USD
Precision BioSciences, Inc. (DTIL)
4.8800
+0.1900
+(4.05%)
At close: May 20 at 4:00:01 PM EDT
4.8800
0.00
(0.00%)
After hours: May 20 at 6:38:56 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -2.2 | -2.24 | -8.74 | -7.55 |
| Low Estimate | -2.31 | -2.4 | -8.95 | -9.24 |
| High Estimate | -2.1 | -2.08 | -8.54 | -5.85 |
| Year Ago EPS | 4.67 | -2.25 | 1 | -8.74 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 4 |
| Avg. Estimate | -- | -- | 2.5M | 22.7M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 5M | 66.5M |
| Year Ago Sales | 49.9M | 576k | 68.7M | 2.5M |
| Sales Growth (year/est) | -100.00% | -100.00% | -96.36% | 808.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -5.07 | -3.13 | -2.94 | -2.42 |
| EPS Actual | 4.67 | -2.25 | -2.14 | -2.21 |
| Difference | 9.74 | 0.88 | 0.81 | 0.21 |
| Surprise % | 192.11% | 28.12% | 27.47% | 8.68% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.2 | -2.24 | -8.74 | -7.55 |
| 7 Days Ago | -1.31 | -1.5 | -10.22 | -8.88 |
| 30 Days Ago | -2.55 | -2.68 | -10.22 | -9.02 |
| 60 Days Ago | -0.07 | -0.33 | -8.62 | -4.52 |
| 90 Days Ago | -0.07 | -0.33 | -8.62 | -4.52 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 2 |
| Up Last 30 Days | 1 | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DTIL | -147.22% | 0.44% | -971.33% | 13.72% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Upgrade | BMO Capital: Market Perform to Outperform | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/30/2024 |
Related Tickers
ACRV Acrivon Therapeutics, Inc.
1.2500
+5.93%
NKTX Nkarta, Inc.
1.8000
+5.88%
TIL Instil Bio, Inc.
16.44
-2.72%
KZR Kezar Life Sciences, Inc.
4.1100
+1.99%
ALEC Alector, Inc.
1.3700
+7.87%
STRO Sutro Biopharma, Inc.
0.8997
+2.44%
RGNX REGENXBIO Inc.
10.00
+2.15%
SPRO Spero Therapeutics, Inc.
0.6802
-1.26%
ETNB 89bio, Inc.
9.03
+17.27%
ADAP Adaptimmune Therapeutics plc
0.2873
-1.37%